| Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain D Sinclair, TD Purves-Tyson, KM Allen, CS Weickert Psychopharmacology 231, 1581-1599, 2014 | 241 | 2014 |
| Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder SG Fillman, D Sinclair, SJ Fung, MJ Webster, C Shannon Weickert Translational psychiatry 4 (2), e365-e365, 2014 | 238 | 2014 |
| Rethinking schizophrenia in the context of normal neurodevelopment VS Catts, SJ Fung, LE Long, D Joshi, A Vercammen, KM Allen, ... Frontiers in cellular neuroscience 7, 60, 2013 | 219 | 2013 |
| Sensory processing in autism spectrum disorders and Fragile X syndrome—From the clinic to animal models D Sinclair, B Oranje, KA Razak, SJ Siegel, S Schmid Neuroscience & Biobehavioral Reviews 76, 235-253, 2017 | 217 | 2017 |
| Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness D Sinclair, SG Fillman, MJ Webster, CS Weickert Scientific reports 3 (1), 3539, 2013 | 119 | 2013 |
| Translational potential of olfactory mucosa for the study of neuropsychiatric illness K Borgmann-Winter, SL Willard, D Sinclair, N Mirza, B Turetsky, S Berretta, ... Translational psychiatry 5 (3), e527-e527, 2015 | 96 | 2015 |
| Transcriptome analysis of male–female differences in prefrontal cortical development CS Weickert, M Elashoff, AB Richards, D Sinclair, S Bahn, S Paabo, ... Molecular psychiatry 14 (6), 558-561, 2009 | 96 | 2009 |
| Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development D Sinclair, MJ Webster, J Wong, CS Weickert Molecular Psychiatry 16 (5), 504-515, 2011 | 88 | 2011 |
| Glucocorticoid receptor 1B and 1C mRNA transcript alterations in schizophrenia and bipolar disorder, and their possible regulation by GR gene variants D Sinclair, JM Fullerton, MJ Webster, C Shannon Weickert PloS one 7 (3), e31720, 2012 | 87 | 2012 |
| Dysregulations of synaptic vesicle trafficking in schizophrenia CN Egbujo, D Sinclair, CG Hahn Current psychiatry reports 18, 1-10, 2016 | 82 | 2016 |
| GABA-B agonist baclofen normalizes auditory-evoked neural oscillations and behavioral deficits in the Fmr1 knockout mouse model of fragile X syndrome D Sinclair, R Featherstone, M Naschek, J Nam, A Du, S Wright, K Pance, ... Eneuro 4 (1), 2017 | 75 | 2017 |
| Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness D Sinclair, SY Tsai, HG Woon, CS Weickert Neuropsychopharmacology 36 (13), 2698-2709, 2011 | 75 | 2011 |
| Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism J Zieba, D Sinclair, T Sebree, M Bonn-Miller, D Gutterman, S Siegel, ... Pharmacology Biochemistry and Behavior 181, 93-100, 2019 | 68 | 2019 |
| Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder D Sinclair, MJ Webster, JM Fullerton, CS Weickert BMC psychiatry 12, 1-13, 2012 | 64 | 2012 |
| Overexpression of neuregulin 1 type III confers hippocampal mRNA alterations and schizophrenia-like behaviors in mice JC Olaya, CL Heusner, M Matsumoto, D Sinclair, MA Kondo, T Karl, ... Schizophrenia bulletin 44 (4), 865-875, 2018 | 35 | 2018 |
| Brain antibodies in the cortex and blood of people with schizophrenia and controls LJ Glass, D Sinclair, D Boerrigter, K Naude, SJ Fung, D Brown, VS Catts, ... Translational psychiatry 7 (8), e1192-e1192, 2017 | 28 | 2017 |
| Microarray analyses of mouse responses to infection by Neospora caninum identifies disease associated cellular pathways in the host response J Ellis, D Sinclair, D Morrison, S Al-Qassab, K Springett, A Ivens Molecular and Biochemical Parasitology 174 (2), 117-127, 2010 | 24 | 2010 |
| Effects of sex and DTNBP1 (dysbindin) null gene mutation on the developmental GluN2B-GluN2A switch in the mouse cortex and hippocampus D Sinclair, J Cesare, M McMullen, GC Carlson, CG Hahn, ... Journal of neurodevelopmental disorders 8, 1-19, 2016 | 21 | 2016 |
| Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia CN Egbujo, D Sinclair, KE Borgmann-Winter, SE Arnold, BI Turetsky, ... Schizophrenia research 168 (1-2), 554-562, 2015 | 20 | 2015 |
| Change in modifiable dementia risk factors during COVID‐19 lockdown: The experience of over 50s in Tasmania, Australia L Bartlett, JJR Brady, M Farrow, S Kim, A Bindoff, H Fair, JC Vickers, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 7 (1 …, 2021 | 19 | 2021 |
